These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 11821471)

  • 61. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
    Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U
    Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique.
    Baranzelli MC; Patte C; Bouffet E; Portas M; Mechinaud-Lacroix F; Sariban E; Roche H; Kalifa C
    J Neurooncol; 1998 May; 37(3):229-39. PubMed ID: 9524081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96.
    Schneider DT; Calaminus G; Reinhard H; Gutjahr P; Kremens B; Harms D; Göbel U
    J Clin Oncol; 2000 Feb; 18(4):832-9. PubMed ID: 10673525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.
    Calaminus G; Kortmann R; Worch J; Nicholson JC; Alapetite C; Garrè ML; Patte C; Ricardi U; Saran F; Frappaz D
    Neuro Oncol; 2013 Jun; 15(6):788-96. PubMed ID: 23460321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D
    J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of survival outcomes in patients with intracranial germinomas treated with radiation alone versus reduced-dose radiation and chemotherapy.
    Fouladi M; Grant R; Baruchel S; Chan H; Malkin D; Weitzman S; Greenberg ML
    Childs Nerv Syst; 1998 Oct; 14(10):596-601. PubMed ID: 9840386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Factors affecting functional outcomes in long-term survivors of intracranial germinomas: a 20-year experience in a single institution.
    Jinguji S; Yoshimura J; Nishiyama K; Aoki H; Nagasaki K; Natsumeda M; Yoneoka Y; Fukuda M; Fujii Y
    J Neurosurg Pediatr; 2013 Apr; 11(4):454-63. PubMed ID: 23373627
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed.
    Eom KY; Kim IH; Park CI; Kim HJ; Kim JH; Kim K; Kim SK; Wang KC; Cho BG; Jung HW; Heo DS; Kang HJ; Shin HY; Ahn HS
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):667-71. PubMed ID: 18514777
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical and Radiologic Features of Pediatric Basal Ganglia Germ Cell Tumors.
    Zhang S; Liang G; Ju Y; You C
    World Neurosurg; 2016 Nov; 95():516-524.e1. PubMed ID: 27567571
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Chemotherapy of disseminated germ cell tumors].
    Kimura G; Akimoto M
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1873-90. PubMed ID: 9797810
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
    Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
    Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
    Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stereotactic radiotherapy for pediatric intracranial germ cell tumors.
    Zissiadis Y; Dutton S; Kieran M; Goumnerova L; Scott RM; Kooy HM; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):108-12. PubMed ID: 11516859
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bains M; Mariani T; Bacik J; Bajorin D; Bosl GJ
    J Clin Oncol; 2000 Jun; 18(12):2413-8. PubMed ID: 10856101
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.
    Fukuoka K; Yanagisawa T; Watanabe Y; Suzuki T; Matsutani M; Kuji I; Nishikawa R
    J Neurosurg Pediatr; 2015 Oct; 16(4):367-71. PubMed ID: 26140394
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
    Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
    Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.